ARQT position history
The shares of Arcutis Biotherapeutics (ARQT) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q1: 3,560,000 shares, $35M, 0.16% of portfolio, New
- 2024 Q2: 26,000 shares, $242K, <0.01% of portfolio, Reduce −99.3%
- 2024 Q3: 26,000 shares, $242K, <0.01% of portfolio
- 2024 Q4: 26,000 shares, $362K, <0.01% of portfolio
- 2025 Q1: 26,000 shares, $407K, <0.01% of portfolio
- 2025 Q2: 26,000 shares, $365K, <0.01% of portfolio
- 2025 Q3: 52,000 shares, $980K, <0.01% of portfolio, Add +100.0%
- 2025 Q4: 26,000 shares, $755K, <0.01% of portfolio, Reduce −50.0%
- 2026 Q1: 26,000 shares, $613K, <0.01% of portfolio
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|